Yahoo
OTC Markets OTCPK - Delayed Quote USD

Epigenomics AG (EPGNF)

1.1200 0.0000 (0.00%)
At close: February 5 at 4:00:00 PM EST
Chart Range Bar
Loading chart for EPGNF
  • Previous Close 1.1200
  • Open 1.1200
  • Bid 0.2500 x 500000
  • Ask 2.2000 x 20000
  • Day's Range 1.1200 - 1.1200
  • 52 Week Range 1.1200 - 1.1200
  • Volume 380
  • Avg. Volume 0
  • Market Cap (intraday) 1M
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) --
  • EPS (TTM) -3.3700
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.

www.epigenomics.com

1

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

EPGNF
0.00%
DAX P (^GDAXI)
5.42%

1-Year Return

EPGNF
0.00%
DAX P (^GDAXI)
7.05%

3-Year Return

EPGNF
65.54%
DAX P (^GDAXI)
75.44%

5-Year Return

EPGNF
80.18%
DAX P (^GDAXI)
64.56%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY15
Revenue 757k
Earnings -952k
Profit Margin -125.76%

Q1

FY15

Q2

FY15

Q3

FY15

Q4

FY15

-3M
-2M
-1M
0
-800.0%
-600.0%
-400.0%
-200.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1.68%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    30k

  • Net Income Avi to Common (ttm)

    -238k

  • Diluted EPS (ttm)

    -3.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    277k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: